ClinicalTrials.Veeva

Menu

Study of the Effect of Lactisole on the Intestinal Glucose Uptake

U

University Ghent

Status and phase

Completed
Phase 2
Phase 1

Conditions

Healthy

Treatments

Dietary Supplement: lactisole
Other: placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT00631293
2008/103

Details and patient eligibility

About

Study of the effect of lactisole on glucose uptake

Enrollment

10 estimated patients

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male subject, between 18 and 50 years
  • General good health condition

Exclusion criteria

  • Overweight (Body Mass Index ≥30)
  • Metabolic disorders
  • History of gastrointestinal disorders
  • Regular (daily) intake of medication
  • Smoking more than 10 cigarettes/day
  • History of drug abuse
  • Exhaustive (> 3 units/day) alcohol consumption
  • Exhaustive (> 5 units/day) caffeine consumption (coffee, tea, cola, or other caffeine based drinks)
  • Recent (in the last 14 days) donation of blood
  • Recent (in the last 2 days) donation of blood plasma
  • Participation in another trial within 4 weeks before the start of the study

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

10 participants in 2 patient groups, including a placebo group

1
Experimental group
Description:
administration of lactisole
Treatment:
Dietary Supplement: lactisole
2
Placebo Comparator group
Description:
administration of placebo
Treatment:
Other: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems